According to a new report Europe Biochips Market, published by KBV research, the Europe Biochips Market would witness market growth of 10.8% CAGR during the forecast period (2019-2025).
The Germany market dominated the Europe Genomics Market by Country in 2018, growing at a CAGR of 11 % during the forecast period. The UK market is expected to witness a CAGR of 10.7% during (2019 - 2025). Additionally, The France market is expected to witness a CAGR of 13.1% during (2019 - 2025).
The Biotechnology and Pharmaceutical Sector market dominated the Spain Biochips Market by End User in 2018, growing at a CAGR of 11.2 % during the forecast period. The Hospitals and Diagnostics Centers market is expected to witness a CAGR of 11.2% during (2019 - 2025). The Academic and Research Institutes market is expected to witness a CAGR of 13% during (2019 - 2025).
The Lab-on-Chip market dominated the Italy Biochips Market by Product in 2018, growing at a CAGR of 10.7 % during the forecast period. The DNA Chip market is expected to witness a CAGR of 10.7% during (2019 - 2025).
Full Report:https://www.kbvresearch.com/europe-biochips-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Fluidigm Corporation, Horiba Ltd., PerkinElmer, Inc., OriGene Technologies, Inc., Dynamic Biosensors GmbH, Illumina, Inc., Qiagen N.V., Bio-Rad Laboratories, Inc., Randox Laboratories Limited, Thermo Fisher Scientific, Inc.
ByProduct
By Application
By End User
By Country
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
